These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 2822918)

  • 1. Current management of low-risk metastatic gestational trophoblastic disease.
    Jones WB
    J Reprod Med; 1987 Sep; 32(9):653-6. PubMed ID: 2822918
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Development of single-agent chemotherapy regimens for gestational trophoblastic disease.
    Homesley HD
    J Reprod Med; 1994 Mar; 39(3):185-92. PubMed ID: 7518517
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A prospective randomized comparison of methotrexate, dactinomycin, and chlorambucil versus methotrexate, dactinomycin, cyclophosphamide, doxorubicin, melphalan, hydroxyurea, and vincristine in "poor prognosis" metastatic gestational trophoblastic disease: a Gynecologic Oncology Group study.
    Curry SL; Blessing JA; DiSaia PJ; Soper JT; Twiggs LB
    Obstet Gynecol; 1989 Mar; 73(3 Pt 1):357-62. PubMed ID: 2536911
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treatment of high-risk gestational trophoblastic disease with methotrexate, actinomycin D, and cyclophosphamide chemotherapy.
    Lurain JR; Brewer JI
    Obstet Gynecol; 1985 Jun; 65(6):830-6. PubMed ID: 2987766
    [TBL] [Abstract][Full Text] [Related]  

  • 5. High-risk metastatic gestational trophoblastic tumors. Current management.
    Lurain JR
    J Reprod Med; 1994 Mar; 39(3):217-22. PubMed ID: 7518518
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Management of high-risk gestational trophoblastic disease.
    Surwit EA
    J Reprod Med; 1987 Sep; 32(9):657-62. PubMed ID: 2822919
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Persistent gestational trophoblastic disease: results of MEA (methotrexate, etoposide and dactinomycin) as first-line chemotherapy in high risk disease and EA (etoposide and dactinomycin) as second-line therapy for low risk disease.
    Dobson LS; Lorigan PC; Coleman RE; Hancock BW
    Br J Cancer; 2000 May; 82(9):1547-52. PubMed ID: 10789722
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Alternating weekly chemotherapy with etoposide-methotrexate-dactinomycin/cyclophosphamide-vincristine for high-risk gestational trophoblastic disease.
    Soper JT; Evans AC; Clarke-Pearson DL; Berchuck A; Rodriguez G; Hammond CB
    Obstet Gynecol; 1994 Jan; 83(1):113-7. PubMed ID: 8272290
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Methotrexate in gynecologic oncology].
    Isonishi S; Terashima Y
    Gan To Kagaku Ryoho; 1996 Dec; 23(14):1896-900. PubMed ID: 8978793
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treatment for low-risk gestational trophoblastic disease: comparison of single-agent methotrexate, dactinomycin and combination regimens.
    Abrão RA; de Andrade JM; Tiezzi DG; Marana HR; Candido dos Reis FJ; Clagnan WS
    Gynecol Oncol; 2008 Jan; 108(1):149-53. PubMed ID: 17931696
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Metastatic gestational trophoblastic disease: experience at the New England Trophoblastic Disease Center, 1965 to 1985.
    DuBeshter B; Berkowitz RS; Goldstein DP; Cramer DW; Bernstein MR
    Obstet Gynecol; 1987 Mar; 69(3 Pt 1):390-5. PubMed ID: 3029641
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The management of gestational trophoblastic tumors with etoposide, methotrexate, and actinomycin D.
    Soto-Wright V; Goldstein DP; Bernstein MR; Berkowitz RS
    Gynecol Oncol; 1997 Jan; 64(1):156-9. PubMed ID: 8995566
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Methotrexate monotherapy for high-risk gestational trophoblastic neoplasia after therapy with etoposide, methotrexate, and dactinomycin: a case report.
    Taran A; Ignatov A; Smith B; Bischoff J; Costa SD
    Am J Obstet Gynecol; 2008 Nov; 199(5):e6-8. PubMed ID: 18984073
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Metastatic gestational trophoblastic disease: prognostic factors in previously untreated patients.
    Soper JT; Clarke-Pearson D; Hammond CB
    Obstet Gynecol; 1988 Mar; 71(3 Pt 1):338-43. PubMed ID: 2831487
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Gestational trophoblastic disease.
    Hammond CB; Olt GJ
    Curr Ther Endocrinol Metab; 1994; 5():567-70. PubMed ID: 7704794
    [No Abstract]   [Full Text] [Related]  

  • 16. Gestational trophoblastic disease: does central nervous system chemoprophylaxis have a role?
    Gillespie AM; Siddiqui N; Coleman RE; Hancock BW
    Br J Cancer; 1999 Mar; 79(7-8):1270-2. PubMed ID: 10098770
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Gestational trophoblastic disease presenting as a large metastasis to the finger.
    Hetzel DJ; Olt GJ; Sorosky JI; Mortel R; Singapuri K; Podczaski ES
    Gynecol Oncol; 1996 Oct; 63(1):123-6. PubMed ID: 8898181
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Placental site trophoblastic tumor: an overview.
    Bonazzi C; Urso M; Dell'Anna T; Sacco S; Buda A; Cantú MG
    J Reprod Med; 2004 Aug; 49(8):585-8. PubMed ID: 15457847
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Magnetic resonance tomography in follow-up of hydatidiform mole].
    Marth C; Judmaier W; Helweg G; Schwegel P; Wicke K; Zeimet AG; Daxenbichler G; Hetzel H
    Geburtshilfe Frauenheilkd; 1992 Aug; 52(8):501-3. PubMed ID: 1327942
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Management of low-risk metastatic gestational trophoblastic tumors.
    DuBeshter B; Berkowitz RS; Goldstein DP; Bernstein MR
    J Reprod Med; 1991 Jan; 36(1):36-9. PubMed ID: 1848898
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.